Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascorbic Acid Treatment for Patients With Combined Mineralocorticoid and Glucocorticoid Deficiency Secondary to Nicotinamide Nucleotide Transhydrogenase Mutation

NCT02838472 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT02838472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascorbic Acid Treatment for Patients With Combined Mineralocorticoid and Glucocorticoid Deficiency Secondary to Nicotinamide Nucleotide Transhydrogenase Mutation
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2017
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucocorticoids deficiency